Taibang Biologic Group
Blood & Organ Banks · China · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Jialong International Building 17-18 Cha...Phone Number
+86 1065983111Website
www.chinabiologic.comRevenue
$279.8 MillionStock Symbol
CBPOIndustry
ZI Rank: 3
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
5
1
3
3
About Taibang Biologic Group
Founded in 2002, Taibang Bio Group is an advanced comprehensive blood products and biopharmaceutical enterprise. Its core business includes the research and development, production and sales of blood products and biological products. Taibang Bio Group has a blood product production base with advanced technical standards; has a high-quality R&D team and blood product R&D laboratory; has three categories covering human albumin, human immunoglobulin and human coagulation factors, more than 20 product specifications product line of blood products.Explore more
Taibang Biologic Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Taibang Biologic Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Taibang Biologic Group is spiking on competitors!
Taibang Biologic Group, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Taibang Biologic Group had a recent Job posting/layoffs
Check if Taibang Biologic Group has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Taibang Biologic Group recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Taibang Biologic Group
Product Launch: Get notified when Taibang Biologic Group launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Taibang Biologic Group has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Taibang Biologic Group is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Taibang Biologic Group is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Taibang Biologic Group.
Taibang Biologic Group financials insights
Gather financial insights about Taibang Biologic Group, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Unspecified
$300M
Taibang Biologic Group Tech Stack
Taibang Biologic Group News & Media
China Biologic Announces Completion of Going Private Transaction
BEIJING, April 20, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced the completion of its merger (the "Merger") with CBPO Group Limited...China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020
BEIJING, March 30, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial results for the fourth quarter and fiscal year of 2020. Fourth Quarter 2020 Financial Highlights Total sales in the fourth quarter of 2020 increased by 9.7% in USD terms and 3.2% in RMB terms to $112.1 million from $102.2 million in the same quarterChina Biologic Announces Shareholders' Approval of Merger Agreement
BEIJING, March 1, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that, at an extraordinary general meeting (the "EGM") held today, the Company's shareholders voted in favor of the proposal to authorize and approve the previously announced agreement and plan of merger, dated as of November 19, 2020 (the "Merger Agreement"), among the Company,China Biologic Announces Extraordinary General Meeting of Shareholders
BEIJING, Jan. 25, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that it has called an extraordinary general meeting of shareholders...
Read more news
Top Blood & Organ Banks Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Taibang Biologic Group
Sign Up For FreeTo access detailed company insights
Founded in 2002, Taibang Bio Group is an advanced comprehensive blood products and biopharmaceutical enterprise. Its core business includes the research and development, production and sales of blood products and biological products. Taibang Bio Group has a blood product production base with advanced technical standards; has a high-quality R&D team... Read More
